-
61
-
62
-
63
Protective role of ginsenoside Rg1 in the dynamic progression of liver injury to fibrosis: a preclinical meta-analysis
Published 2025-01-01Subjects: Get full text
Article -
64
Preclinical pharmaco-toxicological screening of biomimetic melanin-like nanoparticles as a potential therapeutic strategy for cutaneous melanoma
Published 2025-02-01“…The current study presents the preclinical evaluation of MEL-NPs as a potential nanomedicine for CM management.MethodsMEL-NPs were produced through the oxidative polymerization of dopamine and characterized via electron microscopy and UV-VIS spectroscopy. …”
Get full text
Article -
65
Preclinical Cognitive Markers of Alzheimer Disease and Early Diagnosis Using Virtual Reality and Artificial Intelligence: Literature Review
Published 2025-01-01“… Abstract BackgroundThis review explores the potential of virtual reality (VR) and artificial intelligence (AI) to identify preclinical cognitive markers of Alzheimer disease (AD). …”
Get full text
Article -
66
Comprehensive review of preclinical evaluation strategies for COVID-19 vaccine candidates: assessing immunogenicity, toxicology, and safety profiles
Published 2025-02-01“…Based on guidelines, preclinical studies are recommended to assess the safety and potency of COVID-19 vaccines in appropriate in vitro and in vivo settings. …”
Get full text
Article -
67
-
68
-
69
PretoxTM: a text mining system for extracting treatment-related findings from preclinical toxicology reports
Published 2025-02-01Subjects: Get full text
Article -
70
Phospholipogenic Pharmaceuticals Are Associated with a Higher Incidence of Histological Findings than Nonphospholipogenic Pharmaceuticals in Preclinical Toxicology Studies
Published 2012-01-01“…While phospholipidosis is thought to be an adaptive response to chemical challenge, many phospholipogenic compounds are known to display adverse effects in preclinical species and humans. To investigate the link between phospholipogenic administration and incidence of preclinical histological signals, an internal AstraZeneca in vivo toxicology report database was searched to identify phospholipogenic and nonphospholipogenic compounds. …”
Get full text
Article -
71
A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells
Published 2025-01-01“…Furthermore, SAP UCAR-T cells maintained process stability during scale-up production, indicating the potential for large-scale manufacturing.DiscussionOur findings highlight the SAP module as a promising strategy for the preclinical development of anti-CD70 UCAR-T, paving the way for an 'off-the-shelf' cell therapy product.…”
Get full text
Article -
72
-
73
-
74
-
75
Targeting early tau pathology: probiotic diet enhances cognitive function and reduces inflammation in a preclinical Alzheimer’s model
Published 2025-01-01Subjects: “…Preclinical Alzheimer’s disease…”
Get full text
Article -
76
Detecting early cognitive deficits in preclinical Alzheimer’s disease using a remote digital multi-day learning paradigm
Published 2025-01-01“…Our results suggest that diminished MDLCs track with advanced AD pathophysiology, and demonstrate how a digital multi-day learning paradigm can provide novel insights about cognitive decline during preclinical AD.…”
Get full text
Article -
77
Targeting protein kinase C-α prolongs survival and restores liver function in sepsis: Evidence from preclinical models
Published 2025-02-01“…This study identified protein kinase C-α (PKCα) as a novel target for managing excretory liver function during sepsis. Using a preclinical murine sepsis model, we found that both PKCα knockout and the use of a PKCα-inhibitor midostaurin successfully restored liver function without hindering the host’s response or ability to clear the pathogen, highlighting PKCα’s vital role in excretory liver failure. …”
Get full text
Article -
78
Preclinical use of a clinically-relevant scAAV9/SUMF1 vector for the treatment of multiple sulfatase deficiency
Published 2025-01-01“…Further, a GLP toxicology study conducted in rats demonstrates favorable overall safety of this approach. Conclusions These preclinical studies highlight the potential of our AAV9/SUMF1 vector, the design of which is directly translatable for clinical use, as a gene replacement therapy for MSD patients.…”
Get full text
Article -
79
-
80